Những podcast Lancet Respiratory Medicine hay nhất (2023)

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Richard Costello 11:38

22h ago11:38

11:38

Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Keiju Aokage 5:51

16d ago5:51

5:51

Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Carol Hodgson 19:16

1M ago19:16

19:16

Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Emma Grainger 13:06

3M ago13:06

13:06

Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Vivienne Kahlmann and Catharina Moor 9:00

4M ago9:00

9:00

Vivienne Kahlmann and Catharina Moor discuss a study looking at online mindfulness-based cognitive behaviour treatment to address fatigue associated with sarcoidosis.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Yves Lacasse 17:15

7M ago17:15

17:15

Yves Lacasse joins The Lancet Respiratory Medicine to discuss a meta-analysis on the effectiveness of home oxygen use for patients with COPD.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Rachael Evans 13:28

8M ago13:28

13:28

Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Daniel Munblit and Dale Needham 16:37

9M ago16:37

16:37

Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Daiana Stolz 10:16

10M ago10:16

10:16

Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Ablo Wachinou 10:39

12M ago10:39

10:39

Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Peter Openshaw and Felicity Liew 14:46

12M ago14:46

14:46

Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Dinh Bui 5:31

1y ago5:31

5:31

Dr Dinh Bui discusses the association between very-to-moderate preterm birth and lung function deficits and COPD at age 53.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Ruvim Izickson 8:41

1y ago8:41

8:41

Ruvim Izickson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Wisia Wedzicha 9:05

1y ago9:05

9:05

Wisia Wedzicha discusses findings of a trial of a vaccine for the prevention of COPD exacerbations and provides her insights for future research.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Eileen Rubin 17:05

1y ago17:05

17:05

Eileen Rubin, author of a paper on advancing precision medicine for acute respiratory distress syndrome discusses her delayed diagnosis and how clinician and researcher goals can differ from those of patients.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Daniel Altmann 1:56:11

1+ y ago1:56:11

1:56:11

Daniel Altmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vaccination programmes.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Michael Kreuter on interstitial lung disease 8:28

1+ y ago8:28

8:28

Comment author Michael Kreuter discusses a series of papers published in the Lancet and the Lancet Respiratory Medicine on interstitial lung disease.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19 12:04

1+ y ago12:04

12:04

Bairbre McNicholas and Jie Li discuss an open label superiority meta-trial looking at the efficacy of awake prone positioning for patients with COVID-19 acute hypoxaemic respiratory failure.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Charles Sprung and authors on end-of-life practices in ICUs globally 15:42

1+ y ago15:42

15:42

Charles Sprung and fellow co authors Christiane Hartog, Joseph Nates, and Gavin Joynt discuss the Ethicus-II study, which looked at differences in end-of-life care in nearly 200 ICUs across 36 countries.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma 13:17

1+ y ago13:17

13:17

Christopher Brightling discusses the effect of blocking thymic stromal lymphopoietin (TSLP) with tezepelumab in patients with moderate-to-severe uncontrolled asthma.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
COVID-19 associated aspergillosis 6:36

2y ago6:36

6:36

Dr. Paul Verweij discusses a Personal View published in TLRM on COVID-19 associated aspergillosis.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
COVID-19: Pathophysiology and phenotypes 9:19

2y ago9:19

9:19

Dr. Ignacio Rubio discusses a comprehensive review of the pathophysiology and phenotypes of COVID-19, the first in a Series of four papers about the pathophysiology of acute disease.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Cytokine adsorption and severe COVID-19 pneumonia 9:54

2y ago9:54

9:54

Dr. Kiran Shekar discusses a randomized controlled trial looking at cytokine adsorption in patients with severe COVID-19 pneumonia.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Chronic cough and long COVID 11:32

2y ago11:32

11:32

Dr Fan Chung discuses confronting COVID-19-associated cough and the post-COVID syndrome.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Mepolizumab and the treatment of chronic rhinosinusitis 7:16

2y ago7:16

7:16

Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitisBởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Inhaled budesonide in the treatment of early COVID-19 10:25

2y ago10:25

10:25

Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Antacid therapy in IPF: The Lancet Respiratory Medicine: June 23, 2017 11:55

2y ago11:55

11:55

Kerri Johannson from the University of Calgary discusses why recent treatment guidelines on the use of antacid therapy in patients with IPF have caused controversy.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Laparoscopic anti-reflux surgery and IPF 9:08

2y ago9:08

9:08

Dr. Ganesh Raghu discusses the highly anticipated results of the WRAP-IPF trial, borne out of debate surrounding the role of GER in the pathogenesis and progression of IPF, and conflicting findings from retrospective studies of antacid therapies on survival and disease progression.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Tocilizumab and COVID-19 5:45

2y ago5:45

5:45

Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Interferon treatment and COVID-19 6:34

2y ago6:34

6:34

Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Evaluating deterioration in patients with acute COVID-19 8:30

2y ago8:30

8:30

Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Treatment options in patients with systemic sclerosis-associated interstitial lung disease 15:46

2y ago15:46

15:46

Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
COVID-19 and severe influenza 8:09

2+ y ago8:09

8:09

Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
The second wave and homeless populations 7:57

2+ y ago7:57

7:57

Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Corticosteroids, COPD, asthma and COVID-19 9:42

2+ y ago9:42

9:42

Dr. Anna Schultze discusses inhaled corticosteroid use in COPD and asthma patients and whether they have either a protective or harmful effect when related to COVID-19Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Novel strategies to drive down the global burden of asthma 11:03

2+ y ago11:03

11:03

Richard Beasley discusses a Series of three papers in The Lancet and The Lancet Respiratory Medicine that consider the promise of novel strategies to drive down the global burden of asthma.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
The pathology of suspected EVALI 12:58

2+ y ago12:58

12:58

Dr. Reagan-Steiner and Dr. Gary about pathlogical findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury, or EVALI.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Wheezing illness and RSV-LRTI 5:31

2+ y ago5:31

5:31

Dr. Tina Hartert discusses a new study that aimed to evaluate the strength for a causal effect of Respiratory Syncytial Virus-Lower Respiratory Tract Infection (RSV-LRTI) in subsequent chronic wheezing illness to inform public health expectations for RSV vaccines.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Antibiotic use in infancy and asthma incidence 7:27

3y ago7:27

7:27

Authors of a new population-based study on the association between antibiotic use in infancy and risk of asthma later in life discuss the results of their trial and how they might influence paediatricians and parents.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Guidance on the development of prediction models for critical care 10:59

3y ago10:59

10:59

David Maslove and Daniel E. Leisman discuss their recent paper published in Critical Care Medicine discussing guidance on the development of prediction models for critical careBởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Potential exacerbations in patients with COPD 4:46

3y ago4:46

4:46

Don Sin discusses a new tool for clinicians to use to detect potential exacerbations in patients with chronic obstructive pulmonary disorder.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
CPAP and mild obstructive sleep apnea 6:25

3+ y ago6:25

6:25

Authors of the MERGE Trial discuss treatment of mild obstructive sleep apnea and the effectiveness of continuous positive airway pressure, or CPAP, in the treatment of patients with mild OSABởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
An algorithm for EVALI 12:13

3+ y ago12:13

12:13

Authors from a new case series talk about the development of an algorithm they developed for the diagnosis and treatment of e-cigarette or vaping product use-associated lung injury, or EVALI.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Lung transplants from Hepatitis C viremic donors 6:20

3+ y ago6:20

6:20

Dr. Marcelo Cypel discusses a trial looking at lung transplantation from Hepatitis C viremic donors.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Looking to the future of cystic fibrosis care 8:37

3+ y ago8:37

8:37

Dr Scott Bell and Dr Felix Ratjen discuss The Lancet Respiratory Medicine's Cystic Fibrosis Commission on the future of cystic fibrosis care.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Pamrevlumab and idiopathic pulmonary fibrosis 6:27

3+ y ago6:27

6:27

Dr. Luca Richeldi discusses a trial looking at pamrevlumab, an anti-connective tissue growth factor therapy for the treatment of idiopathic pulmonary fibrosiBởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Nicotine patches, e-cigarettes, and smoking cessation 14:41

3+ y ago14:41

14:41

Dr. Natalie Walker discusses a trial she and her colleagues conducted looking at the effectiveness of nicotine patches used in conjunction with e-cigarettes for smoking cessation.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Tuberculosis and the microbiome 9:35

3+ y ago9:35

9:35

Grant Theron discusses growing evidence of the importance of the lung and gut microbiomes in tuberculosis, and how this knowledge might affect the future of treatment.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Antibiotics and non-severe exacerbations of bronchiectasis in children 5:39

3+ y ago5:39

5:39

Dr Vikas Goyal discuses the use of oral antibiotic treatment in non-severe exacerbations of bronchiectasis in children.Bởi The Lancet

L

Listen to The Lancet Respiratory Medicine

1
Use of extended-criteria donors for lung transplantation 8:39

3+ y ago8:39

8:39

Dr Gabriel Loor discusses a new study looking at how the normothermic portable Organ Care System works to improve donor lungs for transplantation.Bởi The Lancet

Podcast đáng để nghe

TÀI TRỢ BỞI

Podcast Lancet Respiratory Medicine

Download the App!

Podcast đáng để nghe

TÀI TRỢ BỞI

Hướng dẫn sử dụng nhanh